Contraception 1997-05-01

Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.

F Z Stanczyk

Index: Contraception 55(5) , 273-82, (1997)

Full Text: HTML

Abstract

The purpose of the present report is to summarize the most important pharmacokinetic features of the new progestogens. In addition, the question of whether or not gestodene, in comparison to desogestrel, has an influence on the pharmacokinetics of ethinylestradiol (EE2) will be addressed.

Related Compounds

  • Gestodene
  • Ethynyl estradiol
  • Desogestrel

Related Articles:

Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?

2013-10-01

[Obstet. Gynecol. Clin. North Am. 21(2) , 299-319, (1994)]

Activation of NF-kappaB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens.

1980-03-01

[Gynecol. Endocrinol. 26(4) , 265-9, (2010)]

17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.

2012-08-01

[Gynecol. Endocrinol. 28(8) , 606-10, (2012)]

Phase of oral contraceptive cycle and endurance capacity of rowers.

2011-12-01

[Percept. Mot. Skills 113(3) , 764-72, (2011)]

Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets.

2012-01-01

[J. Fam. Plann. Reprod. Health Care 38(1) , 2-6, (2012)]

More Articles...